SCHEMBL896797

SCHEMBL896797

CON=CC(=O)N(C)c1ccccc1COc1cc(C)ccc1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.40
PTGDR2 Q9Y5Y4 1/20 0.39
TSHR P16473 2/20 0.38
MAPT P10636 2/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
TDP1 Q9NUW8 2/20 0.37
CYP2C9 P11712 2/20 0.37
PPARA Q07869 2/20 0.37
TTR P02766 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2C8 P10632 1/20 0.37
CHRM1 P11229 1/20 0.37
ADRA1A P35348 1/20 0.37
PPARG P37231 1/20 0.37
HTR2B P41595 1/20 0.37
SLCO1B3 Q9NPD5 1/20 0.37
CISD1 Q9NZ45 1/20 0.37
SLCO1B1 Q9Y6L6 1/20 0.37
GAA P10253 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8399059 1.00 SMN1; SMN2 (0.40) SMN1; SMN2PTGDR2TSHRMAPTNPC1
SCHEMBL7646069 1.00 SMN1; SMN2 (0.40) SMN1; SMN2PTGDR2TSHRMAPTNPC1
SCHEMBL8397935 0.92 MRGPRX4 (0.41) SMN1; SMN2TSHRMAPTNPC1RAB9A
SCHEMBL8519544 0.90 PTGDR2 (0.38) SMN1; SMN2PTGDR2TSHRMAPTNPC1
SCHEMBL8396050 0.89 RECQL (0.44) PTGDR2MAPTTDP1CYP1A2ALDH1A1
SCHEMBL8398007 0.88 SMN1; SMN2 (0.39) SMN1; SMN2PTGDR2TSHRMAPTNPC1
SCHEMBL8424504 0.85 PTGDR2 (0.42) SMN1; SMN2PTGDR2TSHRMAPTNPC1
SCHEMBL8400501 0.84 FFAR1 (0.40) MAPTNPC1ALDH1A1HTTLMNA
SCHEMBL9279878 0.84 PTGDR2 (0.41) SMN1; SMN2PTGDR2TSHRMAPTNPC1
SCHEMBL8397983 0.84 TDP1 (0.41) SMN1; SMN2MAPTNPC1RAB9ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020133846-A1 Method for protecting plants RYALS JOHN ANDREW (US) 2002-09-19 US claimed
US-8598176-B2 Pyridazine compound and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-12-03 US disclosed
US-8258136-B2 Pyridazine compound and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-09-04 US disclosed
US-20120083605-A1 PYRIDAZINE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED 2012-04-05 US disclosed
EP-1958948-B1 PYRIDAZINE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL CO (JP) 2011-10-05 EP disclosed
US-8022073-B2 Substituted pyridazine compounds and fungicidal uses thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-09-20 US disclosed
EP-1958946-B1 PYRIDAZINE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL CO (JP) 2011-02-23 EP disclosed
WO-2010035899-A1 PYRIDINE COMPOUND AND USE THEREOF FOR PEST CONTROL 住友化学株式会社 (JP) 2010-04-01 WO disclosed
US-20090275589-A1 Pyridazine Compound and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-11-05 US disclosed
US-20090156608-A1 Pyridazine Compound and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-06-18 US disclosed
EP-1958948-A1 PYRIDAZINE COMPOUND AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2008-08-20 EP disclosed
EP-1958946-A1 PYRIDAZINE COMPOUND AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2008-08-20 EP disclosed
EP-0644183-B1 Process of producing N-alkylacetamides SHIONOGI & CO (JP) 1999-06-02 EP disclosed
US-5693859-A REACTING ORTHO-SUBSTITUTED PHENYL ALPHA-KETO ACID HALIDE WITH AN AMINE YIELDS SUBSTITUTED PHENYL ALPHA-KETAMIDE SHIONOGI & CO., LTD. (JP) 1997-12-02 US disclosed
US-5502252-A FUNGICIDES FOR RICE AND CUCUMBERS SHIONOGI & CO., LTD. (JP) 1996-03-26 US disclosed
US-5498792-A Process of producing N-alkylacetamides SHIONOGI & CO., LTD. (JP) 1996-03-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156608-A1 Pyridazine Compound and Use Thereof PLPBP, PNPO, PDXK SMN1; SMN2 2463/4885PTGDR2 683/4885TSHR 2386/4885
US-20120083605-A1 PYRIDAZINE COMPOUND AND USE THEREOF PLPBP, PNPO, PDXK SMN1; SMN2 2463/4885PTGDR2 683/4885TSHR 2386/4885
US-20090275589-A1 Pyridazine Compound and Use Thereof PLPBP, PNPO, PDXK SMN1; SMN2 2463/4885PTGDR2 683/4885TSHR 2386/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.